• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用放射性标记的5-氟尿嘧啶进行的代谢与分布研究。

Metabolic and distribution studies with radiolabeled 5-fluorouracil.

作者信息

Young D, Vine E, Ghanbarpour A, Shani J, Siemsen J K, Wolf W

出版信息

Nuklearmedizin. 1982 Feb;21(1):1-7.

PMID:6281741
Abstract

5-Fluorouracil (5-FU) is an effective anti-tumor drug, which has been used both as a single agent and in combination with other chemotherapeutic agents for the treatment of tumors such as breast and colorectal carcinoma. We synthesized 5-FU with trace amounts of 18F-5-FU and administered the compounds intravenously to 6 cancer patients. The patients were scanned at 2 hr intervals for 12 hrs and their urine collected whenever possible. We also injected 5-FU with the tracer 18F-5-FU, at pharmacological doses, into non-tumored rats, and sampled their bile and blood for 95 mins post-injection. For comparison, 2-14C-5-FU was injected into non-tumored rats and their bile and blood sampled at the same intervals. Minute quantities of rat bile and serum were analyzed chromatographically by high-performance TLC. 5-FU and two of its metabolites (FBAL and FUPA) were identified and quantified by this technique. Both percentage and absolute amounts of 5-FU in the bile follow comparative kinetic patterns. While the liver and the urinary bladder were clearly observable in all 16 patients, the detectability of the gall-bladder was correlated to the inverse of the alkaline phosphatase level in the blood. This work suggests that the diversity of the 5-FU metabolism in cancer patients may allow the use of 18F-5-FU as a probe for understanding those individual variabilities in clinical situations.

摘要

5-氟尿嘧啶(5-FU)是一种有效的抗肿瘤药物,已被用作单一药物以及与其他化疗药物联合用于治疗乳腺癌和结直肠癌等肿瘤。我们合成了含有微量18F-5-FU的5-FU,并将这些化合物静脉注射给6名癌症患者。患者每隔2小时扫描一次,共扫描12小时,并尽可能收集尿液。我们还将药理剂量的5-FU与示踪剂18F-5-FU注射到未患肿瘤的大鼠体内,并在注射后95分钟采集它们的胆汁和血液样本。作为对照,将2-14C-5-FU注射到未患肿瘤的大鼠体内,并在相同时间间隔采集它们的胆汁和血液样本。用高效薄层层析法对微量大鼠胆汁和血清进行色谱分析。用该技术鉴定并定量了5-FU及其两种代谢产物(FBAL和FUPA)。胆汁中5-FU的百分比和绝对量均呈现出比较性的动力学模式。在所有16名患者中,肝脏和膀胱都清晰可见,而胆囊的可检测性与血液中碱性磷酸酶水平呈负相关。这项研究表明,癌症患者中5-FU代谢的多样性可能使18F-5-FU能够用作一种探针,以了解临床情况下的个体差异。

相似文献

1
Metabolic and distribution studies with radiolabeled 5-fluorouracil.用放射性标记的5-氟尿嘧啶进行的代谢与分布研究。
Nuklearmedizin. 1982 Feb;21(1):1-7.
2
[In-vivo 19F-MRS study of 5-fluorouracil (5-FU) metabolism on tumors].[5-氟尿嘧啶(5-FU)在肿瘤中代谢的体内19F磁共振波谱研究]
Gan To Kagaku Ryoho. 1991 Jan;18(1):75-80.
3
[5-Fluorouracil concentration in various tissues from cancer patients after oral administration of 5-fluorouracil].
Gan To Kagaku Ryoho. 1984 May;11(5):1037-48.
4
Interferon and the incorporation of 5-fluorouracil into RNA of normal tissues and a secondary liver carcinoma in rat.干扰素与5-氟尿嘧啶掺入大鼠正常组织及继发性肝癌RNA的研究
Anticancer Res. 1994 Mar-Apr;14(2A):379-82.
5
NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).1-氨基-2,4-二溴蒽醌(CAS编号:81-49-2)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学与致癌性研究(饲料喂养研究)
Natl Toxicol Program Tech Rep Ser. 1996 Aug;383:1-370.
6
Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium-DTPA-enhanced MRI and localized 19F MRS pharmacokinetic studies of 5-fluorouracil.利用动态钆-二乙三胺五乙酸增强磁共振成像及5-氟尿嘧啶的局部19F磁共振波谱药代动力学研究预测结直肠癌肝转移的化疗反应
NMR Biomed. 2007 Apr;20(2):128-40. doi: 10.1002/nbm.1098.
7
Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high-field 19F-NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols.大鼠模型中的氟嘧啶化疗:通过对离体组织进行高场¹⁹F-NMR光谱法测定氟尿嘧啶代谢物谱,比较局部区域与全身输注方案的治疗反应和毒性。
NMR Biomed. 2004 May;17(3):101-31. doi: 10.1002/nbm.880.
8
[5-Fluorouracil (5-FU) concentration in prostatic tissue of rats and in prostatic cancer patients after oral administration of 5-FU].[口服5-氟尿嘧啶(5-FU)后大鼠前列腺组织及前列腺癌患者体内的5-氟尿嘧啶(5-FU)浓度]
Hinyokika Kiyo. 1990 May;36(5):549-55.
9
Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.5-氟尿嘧啶与血管紧张素转换酶抑制剂联合通过抗血管生成活性对肝细胞癌生长和肝癌发生的协同抑制作用
Oncol Rep. 2007 Feb;17(2):441-6.
10
[Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].[高剂量卡铂、5-氟尿嘧啶和亚叶酸钙时辰疗法治疗晚期结直肠癌]
Srp Arh Celok Lek. 1998 Sep-Oct;126(9-10):355-61.

引用本文的文献

1
Dihydropyrimidine Dehydrogenase Polymorphism c.2194G>A Screening Is a Useful Tool for Decreasing Gastrointestinal and Hematological Adverse Drug Reaction Risk in Fluoropyrimidine-Treated Patients.二氢嘧啶脱氢酶多态性c.2194G>A筛查是降低氟嘧啶治疗患者胃肠道和血液学药物不良反应风险的有用工具。
Curr Issues Mol Biol. 2024 Sep 4;46(9):9831-9843. doi: 10.3390/cimb46090584.
2
The unique potential for noninvasive imaging in modernizing drug development and in transforming therapeutics: PET/MRI/MRS.现代药物研发和治疗变革中无创成像的独特潜力:正电子发射断层扫描/磁共振成像/磁共振波谱分析
Pharm Res. 2011 Mar;28(3):490-3. doi: 10.1007/s11095-010-0293-5. Epub 2010 Oct 1.
3
Fluorinated tracers for imaging cancer with positron emission tomography.
用于正电子发射断层扫描成像癌症的氟化示踪剂。
Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1182-206. doi: 10.1007/s00259-004-1607-9. Epub 2004 Jul 6.
4
An optimized synthesis of 18F-labelled 5-fluorouracil and a reevaluation of its use as a prognostic agent.
Eur J Nucl Med. 1989;15(5):225-9. doi: 10.1007/BF00257538.
5
Levamisole/fluorouracil. A review of their pharmacology and adjuvant therapeutic use in colorectal cancer.左旋咪唑/氟尿嘧啶。其药理学及在结直肠癌辅助治疗中的应用综述。
Drugs Aging. 1991 Jul-Aug;1(4):317-37. doi: 10.2165/00002512-199101040-00007.